BET inhibition reveals glycolytic vulnerability via HIF1α in triple-negative breast cancer
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
In a groundbreaking study published this April in the British Journal of Cancer, a team of researchers has uncovered a ...
In a groundbreaking exploration of the tumor microenvironment, recent research has unveiled intricate interactions between CD8+ T cells and specific ...
In the relentless battle against breast cancer, researchers have long sought to understand the elusive mechanisms that fuel tumor resilience ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine